Which receptor is primarily responsible for respiratory depression when using morphine?

Which receptor is primarily responsible for respiratory depression when using morphine?

• A. Mu-1
• B. Mu-2
• C. Kappa
• D. Delta

Answer: (B)

The receptor primarily responsible for respiratory depression in response to morphine is the Mu-2 receptor. Morphine is an opioid analgesic that exerts its effects through various opioid receptors in the central nervous system, including Mu, Kappa, and Delta receptors. The Mu-2 receptor, in particular, is located in the brainstem, which is crucial for regulating the respiratory drive. When morphine binds to Mu-2 receptors, it decreases the responsiveness of medullary neurons to carbon dioxide, leading to a reduction in the respiratory rate and effectiveness of breathing. This mechanism explains why opioids can cause significant respiratory depression, which is a critical side effect that clinicians must monitor, especially during pain management. The other receptors mentioned, such as Mu-1, Kappa, and Delta, have different effects and functions in the body. For instance, while Mu-1 is associated more with analgesia and less with respiratory depression, Kappa receptors are generally linked to analgesic effects as well as dysphoria and sedation. Delta receptors play a role in modulating pain but do not have the same strong association with respiratory depression as Mu-2. Understanding the specific roles of these receptors is essential for effectively managing the complications associated with opioid use.

The receptor primarily responsible for respiratory depression in response to morphine is the Mu-2 receptor. Morphine is an opioid analgesic that exerts its effects through various opioid receptors in the central nervous system, including Mu, Kappa, and Delta receptors.

The Mu-2 receptor, in particular, is located in the brainstem, which is crucial for regulating the respiratory drive. When morphine binds to Mu-2 receptors, it decreases the responsiveness of medullary neurons to carbon dioxide, leading to a reduction in the respiratory rate and effectiveness of breathing. This mechanism explains why opioids can cause significant respiratory depression, which is a critical side effect that clinicians must monitor, especially during pain management.

The other receptors mentioned, such as Mu-1, Kappa, and Delta, have different effects and functions in the body. For instance, while Mu-1 is associated more with analgesia and less with respiratory depression, Kappa receptors are generally linked to analgesic effects as well as dysphoria and sedation. Delta receptors play a role in modulating pain but do not have the same strong association with respiratory depression as Mu-2. Understanding the specific roles of these receptors is essential for effectively managing the complications associated with opioid use.